Prostate carcinoma
|
|
0.720 |
GeneticVariation
|
BEFREE |
These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).
|
25315430 |
2014 |
Malignant neoplasm of prostate
|
|
0.720 |
GeneticVariation
|
BEFREE |
These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).
|
25315430 |
2014 |
Malignant neoplasm of prostate
|
|
0.720 |
GeneticVariation
|
GWASDB |
Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
|
23555315 |
2013 |
Malignant neoplasm of prostate
|
|
0.720 |
GeneticVariation
|
GWASDB |
Evaluating genetic risk for prostate cancer among Japanese and Latinos.
|
22923026 |
2012 |
Prostate carcinoma
|
|
0.720 |
GeneticVariation
|
GWASCAT |
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.
|
23023329 |
2012 |
Malignant neoplasm of prostate
|
|
0.720 |
GeneticVariation
|
GWASDB |
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.
|
23023329 |
2012 |
Malignant neoplasm of prostate
|
|
0.720 |
GeneticVariation
|
BEFREE |
Here, focusing on its most centromeric region (so-called Region 2: Chr8: 128.14-128.28 Mb) among the multiple PC loci on 8q24, we performed fine mapping and re-sequencing of this critical region and identified SNPs (single nucleotide polymorphisms) between rs1456315 and rs7463708 (chr8: 128,173,119-128,173,237 bp) to be most significantly associated with PC susceptibility (P = 2.00 × 10(-24) , OR = 1.74, 95% confidence interval = 1.56-1.93).
|
20874843 |
2011 |
Prostate carcinoma
|
|
0.720 |
GeneticVariation
|
BEFREE |
Here, focusing on its most centromeric region (so-called Region 2: Chr8: 128.14-128.28 Mb) among the multiple PC loci on 8q24, we performed fine mapping and re-sequencing of this critical region and identified SNPs (single nucleotide polymorphisms) between rs1456315 and rs7463708 (chr8: 128,173,119-128,173,237 bp) to be most significantly associated with PC susceptibility (P = 2.00 × 10(-24) , OR = 1.74, 95% confidence interval = 1.56-1.93).
|
20874843 |
2011 |
Malignant neoplasm of prostate
|
|
0.720 |
GeneticVariation
|
GWASDB |
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.
|
20676098 |
2010 |
Prostate carcinoma
|
|
0.720 |
GeneticVariation
|
GWASCAT |
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.
|
20676098 |
2010 |
Colorectal Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
The genotyping analysis for SNP rs1456315 showed increased association with colorectal cancer with the homozygous CC variant allele (OR: 2.09; χ2 = 4.95; CI: 1.08-4.02; p = 0.02), the minor allele frequency, and additive genotype, respectively (OR: 1.55; χ2 = 6.24; CI: 1.09-2.19; p = 0.01) & (OR: 1.64; χ2 = 4.04; CI: 1.01-2.67; p = 0.04).
|
31487296 |
2019 |
Colorectal Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
In overall analyses, we found that the rs13252298 and rs1456315 were associated with significantly decreased risks of CRC.
|
24330491 |
2013 |
Malignant neoplasm of colon and/or rectum
|
|
0.010 |
GeneticVariation
|
BEFREE |
The genotyping analysis for SNP rs1456315 showed increased association with colorectal cancer with the homozygous CC variant allele (OR: 2.09; χ2 = 4.95; CI: 1.08-4.02; p = 0.02), the minor allele frequency, and additive genotype, respectively (OR: 1.55; χ2 = 6.24; CI: 1.09-2.19; p = 0.01) & (OR: 1.64; χ2 = 4.04; CI: 1.01-2.67; p = 0.04).
|
31487296 |
2019 |
Malignant Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
Moreover, four prostate cancer-associated ncRNA 1 (PRNCR1, rs16901946 G/A, rs13252298 G/A, rs1016343 T/C, and rs1456315 G/A) SNPs were in association with cancer risk.
|
29802154 |
2018 |
Primary malignant neoplasm
|
|
0.010 |
GeneticVariation
|
BEFREE |
Moreover, four prostate cancer-associated ncRNA 1 (PRNCR1, rs16901946 G/A, rs13252298 G/A, rs1016343 T/C, and rs1456315 G/A) SNPs were in association with cancer risk.
|
29802154 |
2018 |
Degenerative polyarthritis
|
|
0.010 |
GeneticVariation
|
BEFREE |
Individuals with PRNCR1 rs1456315 mutant G allele were more likely to suffer from OA in Chinese Han population.
|
29714128 |
2018 |
Female Breast Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
The aim of this study was to assess the relationships between the four selected tagSNPs (rs944289, rs3787016, rs1456315, rs7463708) in the lncRNAs and the risk of female breast cancer in a Chinese population.
|
28607590 |
2017 |
Malignant neoplasm of female breast
|
|
0.010 |
GeneticVariation
|
BEFREE |
The aim of this study was to assess the relationships between the four selected tagSNPs (rs944289, rs3787016, rs1456315, rs7463708) in the lncRNAs and the risk of female breast cancer in a Chinese population.
|
28607590 |
2017 |